Private Capital Management (Minnesota)’s Teva Pharmaceuticals TEVA Stock Holding History

Private Capital Management (Minnesota)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$459K	Buy	26,100 +8,850	+51%	+$199K	0.52%	90
2017 Q2	$573K	Buy	17,250 +2,550	+17%	+$78.9K	0.64%	54
2017 Q1	$472K	Buy	14,700 +1,100	+8%	+$37.5K	0.52%	85
2016 Q4	$493K	Sell	13,600 -600	-4%	-$24K	0.55%	73
2016 Q3	$654K	Buy	14,200 +5,000	+54%	+$261K	0.69%	56
2016 Q2	$462K	Buy	+9,200	New	+$490K	0.46%	96

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Private Capital Management (Minnesota)'s TEVA Position: Q3 2017 in Review

Private Capital Management (Minnesota) increased its Teva Pharmaceuticals (TEVA) stake by 51% in Q3 2017, buying an estimated $199K and bringing the position to 26,100 shares worth $459K. The position accounts for 0.52% of the portfolio, ranked #90.

Private Capital Management (Minnesota) first reported a position in TEVA in Q2 2016 and has held it in 6 quarters since. The position peaked at $654K in Q3 2016. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Private Capital Management (Minnesota) held 26,100 shares of Teva Pharmaceuticals worth $459K as of Q3 2017.
Private Capital Management (Minnesota) bought 8,850 Teva Pharmaceuticals shares in Q3 2017, an estimated $199K.
Teva Pharmaceuticals made up 0.52% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #90 holding.
Private Capital Management (Minnesota) first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 6 quarters since.
Private Capital Management (Minnesota)'s Teva Pharmaceuticals position peaked at $654K in Q3 2016.
535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.